Richard Christopher
Affiliations
- Chief Executive Officer at Lexaria Bioscience Corp. (LEXX), 2025-05-16
- Chief Financial Officer at Invivo Therapeutics Holdings Corp. (NVIV), 2022-11-21
- Executive Vp And Cfo at Icad Inc (ICAD), 2018-12-27
- Chief Financial Officer at Lucid Inc (LCDX), 2014-03-24
- Vp Finance & Cfo at Dusa Pharmaceuticals Inc (DUSA), 2012-12-20
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| LEXX | $2.47 | 27,172 | $67,174.62 | 50,000 | 2024-12-03 | Filing |
| LEXX | $2.24 | 22,828 | $51,216.90 | 22,828 | 2024-12-02 | Filing |
| NVIV | $0.00 | 3,636 | $0.00 | 5,220 | 2020-03-10 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| DUSA | $5.90 | 5,000 | $29,506.50 | 151,002 | 2011-05-12 | Filing |
| DUSA | $5.89 | 50 | $294.50 | 156,002 | 2011-05-12 | Filing |
| DUSA | $5.91 | 5,000 | $29,533.50 | 156,052 | 2011-05-12 | Filing |
| DUSA | $5.91 | 2,500 | $14,774.75 | 161,052 | 2011-05-12 | Filing |
| DUSA | $5.94 | 15,000 | $89,028.00 | 163,552 | 2011-05-12 | Filing |